ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 150 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $864 | -47.1% | 40,383 | 0.0% | 0.00% | -50.0% |
Q1 2023 | $1,633 | -13.3% | 40,383 | -0.2% | 0.00% | -20.0% |
Q4 2022 | $1,883 | -99.9% | 40,483 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $2,100,000 | +10.0% | 40,483 | +0.2% | 0.01% | 0.0% |
Q2 2022 | $1,909,000 | -33.4% | 40,383 | +0.2% | 0.01% | -16.7% |
Q1 2022 | $2,867,000 | -4.8% | 40,283 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $3,012,000 | +30.3% | 40,283 | -1.0% | 0.01% | +20.0% |
Q3 2021 | $2,311,000 | +26.6% | 40,683 | -1.9% | 0.01% | +25.0% |
Q2 2021 | $1,826,000 | -13.7% | 41,483 | -3.3% | 0.00% | -20.0% |
Q1 2021 | $2,115,000 | +15.3% | 42,883 | -1.6% | 0.01% | +25.0% |
Q4 2020 | $1,835,000 | -8.0% | 43,583 | 0.0% | 0.00% | -20.0% |
Q3 2020 | $1,995,000 | -10.7% | 43,583 | -2.0% | 0.01% | -16.7% |
Q2 2020 | $2,233,000 | -2.6% | 44,483 | -0.2% | 0.01% | -14.3% |
Q1 2020 | $2,293,000 | -22.3% | 44,583 | -6.7% | 0.01% | 0.0% |
Q4 2019 | $2,952,000 | +26.4% | 47,783 | +22.9% | 0.01% | +16.7% |
Q3 2019 | $2,336,000 | -30.0% | 38,875 | -1.8% | 0.01% | -25.0% |
Q2 2019 | $3,339,000 | -13.0% | 39,575 | -1.5% | 0.01% | -20.0% |
Q1 2019 | $3,838,000 | +35.2% | 40,175 | +0.3% | 0.01% | +25.0% |
Q4 2018 | $2,838,000 | -16.8% | 40,065 | +0.4% | 0.01% | 0.0% |
Q3 2018 | $3,410,000 | -26.1% | 39,899 | +0.3% | 0.01% | -27.3% |
Q2 2018 | $4,612,000 | +43.3% | 39,790 | 0.0% | 0.01% | +37.5% |
Q1 2018 | $3,219,000 | +42.5% | 39,790 | +3.4% | 0.01% | +60.0% |
Q4 2017 | $2,259,000 | +25.4% | 38,490 | 0.0% | 0.01% | +25.0% |
Q3 2017 | $1,801,000 | +31.1% | 38,490 | +0.8% | 0.00% | 0.0% |
Q2 2017 | $1,374,000 | +16.8% | 38,190 | 0.0% | 0.00% | +33.3% |
Q1 2017 | $1,176,000 | -8.1% | 38,190 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $1,279,000 | +26.1% | 38,190 | +0.3% | 0.00% | 0.0% |
Q3 2016 | $1,014,000 | +10.1% | 38,090 | -8.9% | 0.00% | +50.0% |
Q2 2016 | $921,000 | -24.9% | 41,790 | 0.0% | 0.00% | -33.3% |
Q1 2016 | $1,227,000 | +47.5% | 41,790 | +65.9% | 0.00% | +50.0% |
Q4 2015 | $832,000 | +31.6% | 25,190 | +44.0% | 0.00% | 0.0% |
Q3 2015 | $632,000 | – | 17,490 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 519,035 | $60,156,000 | 15.36% |
Matarin Capital Management, LLC | 201,703 | $23,377,378,000 | 1.69% |
ARMISTICE CAPITAL, LLC | 124,000 | $14,372,000 | 0.94% |
Sapphire Star Partners LP | 7,803 | $904,000 | 0.93% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,631 | $11,431,000 | 0.83% |
FARALLON CAPITAL MANAGEMENT LLC | 1,075,000 | $124,593,000 | 0.77% |
Granahan Investment Management | 100,670 | $11,668,000 | 0.70% |
Virtus ETF Advisers LLC | 6,577 | $762,000 | 0.67% |
AlphaMark Advisors, LLC | 11,115 | $1,288,000 | 0.52% |
Ativo Capital Management LLC | 15,029 | $1,742,000 | 0.48% |